• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.

作者信息

Weber M, Deng S, Arenas J, Aradhye S, Grossman R, Shaw L, Naji A, Barker C, Brayman K L

机构信息

Department of Surgery, University of Pennsylvania, Medical Center, Philadelphia, USA.

出版信息

Transplant Proc. 1997 Dec;29(8):3669-70. doi: 10.1016/s0041-1345(97)01067-1.

DOI:10.1016/s0041-1345(97)01067-1
PMID:9414883
Abstract
摘要

相似文献

1
Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
Transplant Proc. 1997 Dec;29(8):3669-70. doi: 10.1016/s0041-1345(97)01067-1.
2
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.尸体肾移植后他克莫司联合霉酚酸酯或硫唑嘌呤与（改良）环孢素口服溶液联合霉酚酸酯的随机试验：2年结果
Transplantation. 2001 Jul 27;72(2):245-50. doi: 10.1097/00007890-200107270-00014.
3
Single center analysis of mycophenolate mofetil and Neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients.霉酚酸酯与新山地明/泼尼松联合治疗预防非裔美国人和白种人移植受者排斥反应的单中心分析。
Transplant Proc. 1997 Feb-Mar;29(1-2):338-9. doi: 10.1016/s0041-1345(96)00295-3.
4
Rates of acute rejection by recipient race and type of calcineurin inhibitor with mycophenolate mofetil.接受者种族、使用霉酚酸酯时钙调神经磷酸酶抑制剂类型与急性排斥反应发生率的关系。
Transplant Proc. 2002 Dec;34(8):3119-21. doi: 10.1016/s0041-1345(02)03662-x.
5
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients.
Transplant Proc. 2002 Aug;34(5):1617-8. doi: 10.1016/s0041-1345(02)03045-2.
6
Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
Transplant Proc. 1999 Feb-Mar;31(1-2):1131-2. doi: 10.1016/s0041-1345(98)01933-2.
7
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression.使用以他克莫司和霉酚酸酯为基础的免疫抑制治疗可消除心脏移植术后的临床结局种族差异。
Transplantation. 2002 Dec 15;74(11):1568-73. doi: 10.1097/00007890-200212150-00014.
8
Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.
Transplantation. 1998 Jan 27;65(2):242-8. doi: 10.1097/00007890-199801270-00017.
9
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.他克莫司与西罗莫司联合用药对比他克莫司与霉酚酸酯联合用药以及环孢素（新山地明）与西罗莫司联合用药在肾移植中的随机长期试验。I. 一年时的药物相互作用及排斥反应
Transplantation. 2004 Jan 27;77(2):244-51. doi: 10.1097/01.TP.0000101290.20629.DC.
10
The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.肾移植中霉酚酸酯与硫唑嘌呤治疗慢性排斥反应的比较
Transplant Proc. 2000 Nov;32(7):2040-2. doi: 10.1016/s0041-1345(00)01549-9.

引用本文的文献

1
Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant Recipients.由药剂师主导、技术辅助的研究，旨在改善肾移植受者的用药安全、心血管危险因素控制及种族差异。
J Am Coll Clin Pharm. 2018 Dec;1(2):81-88. doi: 10.1002/jac5.1024. Epub 2018 Jun 21.
2
Improving Medication Safety and Cardiovascular Risk Factor Control to Mitigate Disparities in African-American Kidney Transplant Recipients: Design and Methods.改善非裔美国肾移植受者的用药安全和心血管危险因素控制以减轻差异：设计与方法
Contemp Clin Trials Commun. 2018 Mar;9:1-6. doi: 10.1016/j.conctc.2017.11.008. Epub 2017 Nov 23.
3
Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients.
非裔美国肾移植受者在移植中心差异方面的种族差异
Ann Transplant. 2018 Feb 16;23:119-128. doi: 10.12659/aot.907226.
4
Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.心血管危险因素对黑人肾移植受者移植物结局差异的影响。
Hypertension. 2016 Sep;68(3):715-25. doi: 10.1161/HYPERTENSIONAHA.116.07775. Epub 2016 Jul 11.
5
Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients.肾移植受者早期移植物丢失相关关键因素存在显著种族差异。
Am J Nephrol. 2014;40(1):19-28. doi: 10.1159/000363393. Epub 2014 Jun 25.
6
African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.非裔美国人肾移植存活率：免疫抑制的能力平衡固有移植前和移植后风险因素。
Drugs. 2009 Oct 22;69(15):2045-62. doi: 10.2165/11318570-000000000-00000.
7
Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.他克莫司：其在器官移植管理中的药理学及治疗应用的进一步更新
Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.